Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Nonablative radiofrequency treatments, especially microneedle and fractional types, can improve acne scars by 25%–75% after 3-4 sessions, with full results in 3 months and some side effects.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Dutasteride safely promotes hair growth and reduces hair loss, with mild side effects.

Monochromatic light devices, especially the 308-nm excimer laser, are promising for treating alopecia areata but more research is needed.

Sonidegib and vismodegib are similarly effective for advanced basal cell carcinoma, but sonidegib might have a slightly better safety profile.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Hair enzyme activity predicts minoxidil success in Brazilian women with hair loss.

Higher energy, longer exposure, and pulse irradiation improve hair density in androgenetic alopecia treatment.

Platelet-rich plasma therapy shows promise for hair regrowth in alopecia patients.

Azelaic acid micro/nanocrystals, especially with ultrasound and salicylic acid, greatly improve acne treatment.

Combining laser and corticosteroid is not better than corticosteroid alone for treating frontal fibrosing alopecia.

Latanoprost is more effective than minoxidil for treating alopecia areata.

Iron deficiency is not more common in women with hair loss, and neurogenic rosacea may need different treatment.

Betamethasone valerate foam is more effective and safe for treating mild-to-moderate alopecia areata than betamethasone dipropionate lotion.

Multimodal minoxidil microemulsion is more effective in treating hair loss than minoxidil alone.

New treatments for hair loss may target specific pathways and generate new hair follicles.

Stopping the medication infliximab and starting new treatments helped a woman's hair grow back and improved her scalp condition.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Combination therapy works best for female hair loss, increasing density and thickness.

New treatments for hair growth disorders are needed due to limited current options and complex hair follicle biology.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Scalp cooling significantly reduces hair loss in chemotherapy patients.

Bimatoprost solution is effective and safe for long-term use in treating eyelash thinning.

Both Platelet-Rich Plasma and Minoxidil foam increase hair count in women with hair loss, but Minoxidil is more effective. However, women were more satisfied with Platelet-Rich Plasma treatment.

A new gel form of minoxidil is equally effective for hair growth and safer for the heart and other organs than the traditional solution.